Growth Metrics

TriSalus Life Sciences (TLSI) Gross Profit (2022 - 2026)

TriSalus Life Sciences has reported Gross Profit over the past 5 years, most recently at $7.7 million for Q1 2026.

  • For Q1 2026, Gross Profit changed 0.04% year-over-year to $7.7 million; the TTM value through Mar 2026 reached $38.2 million, up 38.78%, while the annual FY2025 figure was $38.2 million, 50.77% up from the prior year.
  • Gross Profit for Q1 2026 was $7.7 million at TriSalus Life Sciences, down from $11.4 million in the prior quarter.
  • Over five years, Gross Profit peaked at $11.4 million in Q4 2025 and troughed at $2.3 million in Q1 2023.
  • A 5-year average of $6.2 million and a median of $6.3 million in 2024 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: soared 136.26% in 2024 and later decreased 0.04% in 2026.
  • Year by year, Gross Profit stood at $2.4 million in 2022, then skyrocketed by 113.24% to $5.1 million in 2023, then skyrocketed by 37.09% to $7.0 million in 2024, then soared by 62.43% to $11.4 million in 2025, then tumbled by 32.98% to $7.7 million in 2026.
  • Business Quant data shows Gross Profit for TLSI at $7.7 million in Q1 2026, $11.4 million in Q4 2025, and $9.7 million in Q3 2025.